Скачать с ютуб JCI’s Conversations with Giants in Medicine: Daniel Drucker в хорошем качестве

JCI’s Conversations with Giants in Medicine: Daniel Drucker

Dr. Dan Drucker, of the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, and the University of Toronto, is a diabetes treatment pioneer. Drucker’s early work explored the biosynthesis, secretion, and action of glucagon, and he later went on to delineate the novel mechanisms of action of glucagon-like peptides (GLP) 1 and 2. His work on GLP-1 and -2 agonists as well as DPP-4 inhibitors provides the foundation for the largest spectrum of drugs for both gut disorders and type 2 diabetes. Watch the full interview to learn about his early stumbles in the lab and his prediction that his next five to ten years in the lab will be very boring.